clelia dispenza - superevent...apr 28, 2017  · dr natascia grimaldi* dr simona todaro* maria di...

26
Radiation synthesis of nanosized drug delivery devices CLELIA DISPENZA Department of Industrial and Digital Innovation University of Palermo ITALY

Upload: others

Post on 30-Jan-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

  • Radiation synthesis of nanosized drug delivery devices

    CLELIA DISPENZADepartment of Industrial and Digital Innovation

    University of Palermo

    ITALY

  • MotivationDevelopment of

    “MODULAR” NANOCARRIERS

    to address the therapeutic needs of specific pathologic states

    Drug ProtectionSite Recognition

    Triggered ReleaseTracking

    Improved biodistribution and pharmacokineticsReduced administered dosesMinimized side-effectsPersonalized therapies

    MULTIPLE FUNCTIONS SEVERAL BENEFITS

    WITH A SINGLE NANODEVICE

  • NanogelsWater-swollen, crosslinked polymer nanoparticles

    • Stable aqueous colloids

    • Soft and conformable

    • Stimuli-responsive

    • MultifunctionalDh= 10 - 100 nm

    • Controlled particle size and surface electrical charge

    • Reactive groups for conjugation of targeting ligands, drugs, etc.

    • Simple production schemes

    • Biocompatibility

    KEY REQUIREMENTS

  • Radiation synthesis of nanogelsPulsed, e-beam irradiation of semi-diluted aqueous solution of an “inert” polymer.

    1. The radiation interacts mainly with water undergoing radiolysis:

    2. Water radiolysis products (mainly .OH) react with the polymer, forming polymer radicals:

    3. Chemical follow-up reactions lead to the formation of crosslinked polymer nanoparticles

    H2O = ∙OH, ∙H, e-aq , HO2∙(O2∙

    -)

    P+ ∙OH = P∙

  • Radiation synthesis of nanogels

    Institute of Nuclear Chemistry and Technology (INCT), Warsaw, Poland.

    NO CATALYSTS OR INITIATORS, ORGANIC SOLVENTS AND SURFACTANTS REQUIRED!

    Industrial-type

    accelerators

    (10 MeV)

    Doses ≥ Sterilisation

    doses Dose per pulse ≈ 10 Gy

    Poly(N-vinyl pyrrolidone)

  • Key process parametersC

    RO

    SSLI

    KIN

    G

    ....

    .. ..

    . ..+

    CONTROL OF SIZE and DENSITY

    INTRAINTER

    PVP NG (0.1) NG (0.2) NG (0.3) NG (0.4) NG (0.5)

    Dia

    me

    tri id

    rod

    ina

    mic

    i (n

    m)

    0

    20

    40

    60

    80

    100

    120

    140

    160

    TEM*

    0 50 100 150 200

    0,05

    0,1

    0,25

    0,5

    Dh, nm

    Po

    lym

    er

    con

    c., w

    t% High dose

    per pulse

    Low doseper pulse

    Poly-N-vinyl pyrrolidone nanogels

    non irradiated

    DLS 40 kGy

    *

    error bars = width of size distribution

    macro

    Polymer concentration and dose per pulse

  • Key process parametersC

    RO

    SSLI

    KIN

    G

    ....

    .. ..

    . ..+

    CONTROL OF SIZE and DENSITY

    INTRAINTER

    Polymer concentration and dose per pulse

    Gel Filtration Chromatography

    • Linear polydisperse polymers transform into monodispersenanoparticles;

    • Size is insensitive to dose in the 20-80 kGy range.

  • Can the combination between primary radicals be neglected?

    OH +OH = H2O2

    If the combination between primary radicals cannot be neglected, then…

    OH +OH = H2O2

    H2O2 +OH = H2O + HO2

    2 HO2 = H2O2 + O2

    P + O2 = POO …

    Key process parameters

  • Pulse length of 50 ns and frequency of 25 Hz for N2O saturated water and aqueous solutions containing PVP and terbutanol.

    H2O2 formation

    0.05%

    Dispenza et al. RSC Adv., 2016, 6, 2582

  • Chemical functionality

    0.1 % wt

    0.5 % wt

    N O HN O

    O

    OH

    HNO

    O

    OH

    NH2

    NG-COOH determined by their ability to extract Ni2+ from water NG-NH2 titrated by reaction with fluorescamine

    COOH

    NH2

    NH2

    OH

    COO-

    COOH

    COOH

    OH

    OH

    Sabatino et al. Polymer , 2013, vol. 54, 54-64Dispenza et al. RSC Adv., 2016, 6, 2582

    Dose-dependant functionalisation

    Branching

  • CONTROL OF (SURFACE) CHEMISTRY AND TOPOLOGY

    ....

    ...

    . +

    GR

    AFT

    ING

    functional acrylic monomer (e.g. acrylic acid)

    (from water radiolysis).

    ..... .

    .. + H2O2/O2

    OX

    IDA

    TIO

    N

    …COOH

    NH2

    NH2

    OH

    COO-

    COOH

    COOH

    OH

    OH

    CR

    OSS

    LIK

    ING

    ....

    .. ..

    . ..+

    CONTROL OF SIZE and DENSITY

    INTRAINTER

    Polymer concentration and dose per pulse

    Polymer concentration, dose per pulse and dose

    Key process parameters

    Polymer concentration, dose per pulse and dose, reactive solutes

  • From nanogel to nanodevice

    COOH

    COOH

    NH2

    COO-

    NH2

    COOHNH2

    COO-

    COO-

    COOH

    COOHCOOH

    OH

    COOH

    PVP-co-AA 40kGy

    z-potential = -25 mVDh = 70 nm PDI = 0.25

  • ANTIBODIES

    Targeting

    Ligands

    PEPTIDES

    COOH

    COOH

    NH2

    COO-

    NH2

    COOHNH2

    COO-

    COO-

    COOH

    COOHCOOH

    OH

    COOH

    From nanogel to nanodevice

  • ANTIBODIES

    NUCLEIC ACIDS

    Targeting

    Ligands

    Therapeutics

    -DOXO-S-S-

    CHEMOTHERAPEUTICS

    PROTEINS

    PEPTIDES

    COOH

    COOH

    NH2

    COO-

    NH2

    COOHNH2

    COO-

    COO-

    COOH

    COOHCOOH

    OH

    COOH

    From nanogel to nanodevice

  • ANTIBODIES

    NUCLEIC ACIDS

    Targeting

    Ligands

    Therapeutics

    -DOXO-S-S-

    CHEMOTHERAPEUTICS

    PEPTIDES

    COOH

    COOH

    NH2

    COO-

    NH2

    COOHNH2

    COO-

    COO-

    COOH

    COOHCOOH

    OH

    COOH DOTA-[Lys3]BBN

    CHELATING AGENTS

    Diagnostic

    tools

    PROTEINS

    From nanogel to nanodevice

  • -DOXO-S-S-

    COOH

    COOH

    NH2

    COO-

    NH2

    COOHNH2

    COO-

    COO-

    COOH

    COOHCOOH

    OH

    COOH DOTA-[Lys3]BBN

    conjugation through amide bond(EDC, Sulfo-NHS)

    FITC, AminoFluo

    TRITC, amino-Atto633

    Fluo. probe

    From nanogel to nanodevice

  • -DOXO-S-S-

    COOH

    COOH

    NH2

    COO-

    NH2

    COOHNH2

    COO-

    COO-

    COOH

    COOHCOOH

    OH

    COOH DOTA-[Lys3]BBN

    Insulin

    1. Biomacromolecules (2012) 13, 1805-1817.2. J. Appl. Polym. Sci (2014) 131(2), 39774-39782.3. Biomaterials (2016) vol. 80, 179-194.4. Molecules (2017) vol 21(11),1594.5. Biological Chemistry (2017) vol. 398(2), pp. 277-287.

    [5]

    [2, 5] [4]

    [4]

    [1,3]

    From nanogel to nanodevice

  • Insulin has important effects in the treatment of neurological diseases, such as Alzheimer’s Disease (AD) for the recovery of memory deficit.

    Alzheimer’s disease

    Insulinresistance

    Insulinin CNS

    AD is also named Type III diabetes

    HealthyAdvancedAlzheimer’s

    The ProblemEfficient delivery of insulin to the central nervous system is hampered by the Blood Brain Barrier.

    Enhanced nose-to-brain insulin delivery through nanogel carriers

  • Enhanced nose-to-brain insulin delivery through nanogel carriers

    Alzheimer’s disease

    Insulinresistance

    Insulinin CNS

    AD is also named Type III diabetes

    HealthyAdvancedAlzheimer’s

    The StrategyIntranasal delivery: the delivery occurs mainly by the olfactory and trigeminal nerve pathways.

    Insulin has important effects in the treatment of neurological diseases, such as Alzheimer’s Disease (AD) for the recovery of memory deficit.

  • INTRANASAL DELIVERY LIMITATIONS

    • Small sprayed volumes

    • Low permeability of nasal mucosa

    • Hormone degradation by protolithic enzymes

    • Harmful effects on the nasal epithelium

    Enhanced nose-to-brain insulin delivery through nanogel carriers

  • NG-In biological evaluation

    NG-Atto633

    NG-In

    NG-InFITC

    NG-Atto633 -InFITC

    PVP-co-AA NGe-beam irradiation

    (40 kGy)

  • NG-In biological evaluation

    URINE ANALISYS

    BIODISTRIBUTION

    NG in blood

  • NG-In biological evaluation

    No deterioration of NASAL MUCOSA

    before after 10 min after 30 min

    BRAIN DISTRIBUTION

    Free InsulinFITC NG-InFITC

    NGs cross NASAL MUCOSA

    No brain immunogenic response.

  • HYPPOCAMPUS CORTEX

    • Radiation engineered NANOGELS are versatile, biocompatible NANOCARRIERS.

    • NG-In is MUCOADHESIVE and RESISTANT TO PROTEOLYTIC ENZYMES.

    • NG-In carries biologically active insulin to the brain with higher efficiency.

    • NG-In can be cleared from blood and organs (where do not induce modifications).

    • Repeated administration effects and studies of disease models are undergoing.

    INSULIN SIGNALINGACTIVATION

    NG-In biological evaluation

  • DIPARTIMENTO DELL’INNOVAZIONEINDUSTRIALE E DIGITALE (UniPa-Italy) Prof. Giuseppe SpadaroProf. Sabina AlessiDr Maria Antonietta SabatinoDr Natascia Grimaldi*Dr Simona Todaro*Maria Di Filippo, PhD studentLorena Anna Ditta, PhD studentAlessia Ajovalasit, PhD student

    ISTITUTO DI BIOLOGIA MOLECOLARE (CNR-Italy)Dr Marta Di CarloDr Pasquale PiconeDr Domenico Nuzzo

    ISTITUTO DI BIOFISICA(CNR-Italy)Dr Donatella BuloneDr Daniela GiacomazzaDr Pier Luigi San Biagio

    ROYAL INSTITUTE OF TECHNOLOGY(Stockholm, Sweden) Prof. Mats Jonsson

    INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY (Warsaw, Poland)Dr. Grazyna PrzybytniakDr. Marta WaloProf. Andrzej Chmielewski

    UNIVERSITY OF MARYLAND(College Park, MD, USA)Prof. Mohamad Al-Sheikhly

    *past PhD student

    STEBICEF (UniPa-Italy)Prof. Antonella Amato Prof. Flavia Mulè

    Acknowledgments

    NG-In team

    PRIN project “NANOMED”

    IAEA CRP 2014- 2018 on “Nanosized Delivery Systems for Radiopharmaceuticals.”

    IAEA CRP 2009- 2012 on "Nanoscale Radiation Engineering for Biomedical Applications”.

    PON HIPPOCRATES

  • THANK YOU FOR YOUR ATTENTION!

    Please, join us for the

    organised in collaboration with IAEA